Sponsor
Theradex
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Theradex appears in 6 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownDHA-Paclitaxel in Treating Patients With Metastatic Prostate CancerNCT00024414 · lead sponsor · 2001-04-01
UNKNOWNPaclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast CancerNCT00025688 · lead sponsor · 2001-01-01
UNKNOWNBBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous TreatmentNCT00014547 · lead sponsor · 2000-11-01
UNKNOWNIO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBCNCT05077709 · collaborator · 2022-04-11
COMPLETEDA Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLCNCT02309892 · collaborator · 2015-04-20
TERMINATEDLTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or PembrolizumabNCT01986426 · collaborator · 2013-11-01
COMPLETEDSponsor roles
collaborator3
lead sponsor3
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.